BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9246403)

  • 1. The pitfalls and complications of radiation therapy for esophageal carcinoma.
    Moni J; Nori D
    Chest Surg Clin N Am; 1997 Aug; 7(3):565-84; discussion 585. PubMed ID: 9246403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of radiotherapy in the management of esophageal cancer].
    Serkies K; Badzio A; Jassem J
    Pol Merkur Lekarski; 2005 Mar; 18(105):332-5. PubMed ID: 15997646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
    Ishikura S; Nihei K; Ohtsu A; Boku N; Hironaka S; Mera K; Muto M; Ogino T; Yoshida S
    J Clin Oncol; 2003 Jul; 21(14):2697-702. PubMed ID: 12860946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative therapy.
    Homs MY; Kuipers EJ; Siersema PD
    J Surg Oncol; 2005 Dec; 92(3):246-56. PubMed ID: 16299791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
    Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S;
    Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
    Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
    Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
    Ohtsu A
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous radiotherapy plus brachytherapy and concurrent chemotherapy for patients with localized esophageal carcinoma--Radiation Oncology Group Study 9207].
    KovĂ cs G;
    Strahlenther Onkol; 2001 May; 177(5):269-70. PubMed ID: 11398614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.